Eli Lilly launches online sales of obesity drug
Novo Nordisk’s biggest competitor on the weight loss market, Eli Lilly, launched the LillyDirect initiative in the US market on Thursday. The initiative enables medication to be delivered directly to patients, breaking a long-standing tradition in the industry, Danish financial media Berlingske writes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.